Language selection

Search

Details for: CLINDAMYCIN INJECTION IN 5% DEXTROSE

Company: BAXTER CORPORATION

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02485451CLINDAMYCIN INJECTION IN 5% DEXTROSECLINDAMYCIN (CLINDAMYCIN PHOSPHATE)300 MG / 50 MLSOLUTIONINTRAVENOUS
02485478CLINDAMYCIN INJECTION IN 5% DEXTROSECLINDAMYCIN (CLINDAMYCIN PHOSPHATE)600 MG / 50 MLSOLUTIONINTRAVENOUS
02485486CLINDAMYCIN INJECTION IN 5% DEXTROSECLINDAMYCIN (CLINDAMYCIN PHOSPHATE)900 MG / 50 MLSOLUTIONINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Consumer Information

This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.

What the medication is used for

Clindamycin Injection in 5% Dextrose is used for the treatment of serious bacterial infections

What it does

Clindamycin Injection in 5% Dextrose reduces the production of key proteins in germs. This prevents growth in germs and reduces the infection.

When it should not be used

You are allergic (hypersensitive) to:

  • Clindamycin
  • Lincomycin
  • Other ingredients in the product (see list of nonmedicinal ingredients).
What the medicinal ingredient is

Clindamycin phosphate

What the non-medicinal ingredients are

Dextrose hydrous, edetate disodium dihydrate and water for injection. It may also contain hydrochloric acid and/or sodium hydroxide for pH adjustment.

What dosage form it comes in

Clindamycin Injection in 5% Dextrose is available in ready-to-use 50 mL GALAXY plastic containers containing clindamycin premixed with 5% Dextrose w/v as a sterile solution.

Each 50 mL GALAXY plastic container contains clindamycin phosphate equivalent to 300 mg, 600 mg or 900 mg clindamycin. The single dose GALAXY plastic containers are available as follows:

300 mg/50 mL, case of 24
600 mg/50 mL, case of 24
900 mg/50 mL, case of 24
Clindamycin Injection in 5% Dextrose is for intravenous infusion only.

Warnings and precautions

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Clindamycin Injection in 5% Dextrose. Talk about any health conditions or problems you may have, including if you:

  • have had intestinal disorders such as:
    • colitis (inflammation of the colon)
    • inflammatory bowel disease
  • have diarrhea or get diarrhea when you take antibiotics
  • suffer from problems with your stomach or intestines (e.g. bowel disease, colitis).
  • suffer from problems with your kidneys or liver.
  • are pregnant or planning to become pregnant. Clindamycin passes to the human fetus
  • are breastfeeding or planning to breastfeed. Clindamycin is passed to the infant through human breast milk. Because of the potential for serious adverse reactions in nursing infants, clindamycin should not be administered to nursing mothers.
  • you have glucose-6-phosphate dehydrogenase (G-6- PD) deficiency and are taking primaquine. You may need to have routine blood tests while taking Clindamycin Injection in 5% Dextrose with primaquine, to monitor for potential blood cell changes.
Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
Interactions with this medication
  • erythromycin (an antibiotic)
  • muscle relaxants used during operations
  • primaquine (antimalarial)
  • Aminoglycosides (a class of antibiotics)
  • St-John’s Wort (Hypericum perforatum)

Proper use of this medication

The health care professional will administer Clindamycin Injection in 5% Dextrose and will:

  • Decide:
    • the dose and rate of administration of the medicine
  • Ensure that:
    • the medicine will be given as an injection (infusion) through the vein
    • the medicine will be given for the full treatment period
    • the medicine will be inspected to determine there is:
      • no discolouration
      • no leaks
      • no solid particles floating in solution
      • no haziness in the solution

Usual Dose

Your doctor will determine the dose and for how long you should receive it.

Long term use of Clindamycin Injection in 5% Dextrose:

  • If you have to use clindamycin for a long time, your doctor may arrange regular liver, kidney and blood tests.
  • Do not miss these check-ups with your doctor.
  • Long term use can also make you more likely to get other infections that do not respond to clindamycin treatment.
This particular product format in GALAXY plastic container is not suitable for use in children 12 years of age and under.

Overdose

If you think you have taken too much Clindamycin Injection in 5% Dextrose, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose

Your healthcare professional will ensure that this product is administered each day and doses are not missed, as it works best when there is a constant amount in the body. If the medicine is stopped too soon, your symptoms may return. If you feel a dose has been missed contact your healthcare professional.

Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by clindamycin phosphate or other antibacterial drugs in the future

Side effects and what to do about them

These are not all the possible side effects you may feel when taking Clindamycin Injection in 5% Dextrose. If you experience any side effects not listed here, contact your healthcare professional. Please also see Warnings and Precautions.

Clindamycin Injection in 5% Dextrose can cause side effects such as:

  • skin reddening, rash, itching, hives
  • throat ulcers, sore throat
  • feeling sick, being sick
  • stomach pain and diarrhea
  • injection site irritation
  • thrombophlebitis (inflammation of the vein due to blood clot)
  • low red blood cells (anemia) with symptoms such as bruising or bleeding
  • low white blood cells (neutropenia) which can lead to an increased chance of infections
  • vaginal infection or vaginitis (inflamed vagina)
Contact your doctor immediately if the following happens:
  • you have symptoms of a severe allergic reaction such as:
    • sudden wheeziness
    • difficulty in breathing
    • swelling of eyelids, face or lips
    • rash or itching (especially affecting the whole body)
    • blistering and peeling of large areas of skin
    • fever
    • cough
    • feeling unwell
    • swelling of the gums, tongue or lips
  • you have symptoms of liver problems such as:
    • yellowing of the skin and whites of the eyes (jaundice).
  • you have symptoms of Clostridium difficile colitis (bowel inflammation) such as:
    • severe, persistent, watery or bloody diarrhea with or without
      • fever
      • abdominal pain or tenderness This may happen months after the last dose of medication. If this occurs, stop taking and contact your doctor right away.

Serious side effects, how often they happen and what to do about them
Symptom / effect Talk with your doctor, nurse, or pharmacist only if severe Talk with your doctor, nurse, or pharmacist in all cases Stop taking drug and get immediate medical help
VERY COMMON
Liver problems with symptoms such a yellowing skin or eyes, abdominal pain, nausea, vomiting  
Common
Diarrhea    
Rash    
Rare
Skin reactions: itching    
Not Known
Clostridium difficileassociated disease (bowel inflammation), with symptoms such as persistent or severe diarrhea, abdominal pain, nausea and vomiting    
Injection site reactions with symptoms as pain, redness and skin irritation    
Serious allergic (hypersensitivity) reaction with symptoms such as swelling of eyes, mouth, throat, difficulty breathing, blistering or peeling skin, rash, itching    

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your health care professional.

How to store

The healthcare professional will store Clindamycin Injection in 5% Dextrose GALAXY plastic containers under appropriate conditions (15˚C to 25˚C). Avoid temperatures above 30°C.

Keep out of the reach and sight of children.

Reporting side effects

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:
    • Fax toll-free to 1-866-678-6789, or
    • Mail to:
      Canada Vigilance Program
      Health Canada
      Postal Locator 0701E
      Ottawa ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

More information

If you want more information about Clindamycin Injection in 5% Dextrose:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/healthcanada.html); or by calling Baxter Corporation at: 1- 888-719-9955
This leaflet was prepared by Baxter Corporation, Mississauga, Ontario L5N 0C2, Canada.

Baxter and GALAXY are trademarks of Baxter International Inc.

Last revised: February 1, 2019

Date modified: